Cases 51 - 60 of 15,343
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Boehringer Ingelheim Corporation et al
as 1:2023cv00848
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Ajanta Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pierce v. Zantac Corporation et al
as 9:2023cv81121
Plaintiff:
Cynthia Pierce
Defendant:
Zantac Corporation, Family Dollar, Sanofi and others
Cause Of Action: 28 U.S.C. § 1346 Wrongful Death
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ALVOGEN, INC.
as 2:2023cv03911
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM INTERNATIONAL GMBH and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Defendant:
ALVOGEN, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ALVOGEN, INC.
as 3:2023cv03911
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM INTERNATIONAL GMBH and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Defendant:
ALVOGEN, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
RICHARTZ et al v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al
as 3:2023cv03584
Plaintiff:
PAUL RICHARTZ and LINDA RICHARTZ
Defendant:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM CORPORATION, BOEHRINGER INGELHEIM USA CORPORATION and others
Cause Of Action: 28 U.S.C. § 1441 Notice of Removal- Product Liability
RICHARTZ et al v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al
as 2:2023cv03584
Plaintiff:
PAUL RICHARTZ and LINDA RICHARTZ
Defendant:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Anobri Pharmaceuticals US, LLC et al
as 1:2023cv00715
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Defendant:
Anobri Pharmaceuticals US, LLC, NanChang Anovent Pharmaceutical Co., Ltd., Shaghai Anovent Pharmaceutical Co., Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Anobri Pharmaceuticals US, LLC et al
as 1:2023cv00716
Plaintiff:
Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH
Defendant:
Anobri Pharmaceuticals US, LLC, NanChang Anovent Pharmaceutical Co., Ltd. and Shanghai Anovent Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ANOBRI PHARMACEUTICALS US, LLC et al
as 2:2023cv03530
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
ANOBRI PHARMACEUTICALS US, LLC, NANCHANG ANOVENT PHARMACEUTICAL CO., LTD. and SHANGHAI ANOVENT PHARMACEUTICAL CO., LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ANOBRI PHARMACEUTICALS US, LLC et al
as 2:2023cv03531
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
ANOBRI PHARMACEUTICALS US, LLC, NANCHANG ANOVENT PHARMACEUTICAL CO., LTD. and SHANGHAI ANOVENT PHARMACEUTICAL CO., LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
